ASPEN PHARMACARE HOLDINGS LIMITED - Notification in terms of section 122(3)
23 August 2019 15:00
APN 201908230045A
Notification in terms of section 122(3)

ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa) ("Aspen Holdings")
Registration number: 1985/002935/06
Share code: APN
ISIN: ZAE000066692
and its subsidiaries (collectively "Aspen" or "the Group")


NOTIFICATION IN TERMS OF SECTION 122(3) OF THE COMPANIES ACT AND PARAGRAPH 3.83(b) OF THE
JSE LISTINGS REQUIREMENTS


In accordance with section 122(3)(b) of the Companies Act, No. 71 of 2008 ("the Act") and paragraph
3.83(b) of the JSE Listings Requirements, holders of ordinary shares in the Company are advised that
Coronation Asset Management (Pty) Limited has formally notified the Company that it has increased its
beneficial interest in the securities of the Company, which it holds on behalf of its clients, to 10.60% of the
ordinary share capital of the Company, effective 23 August 2019.

Aspen will file the required notice with the Takeover Regulation Panel as required in terms of section
122(3)(a) of the Act.



Durban
23 August 2019


Sponsor:
Investec Bank Limited

Date: 23/08/2019 03:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.